It may be early, but some fiery investments have already brought wealth-changing benefits in this young age.
We only have a few weeks until 2025, but some stocks have already been off to race. There are already nine US exchange-listed stocks, and this year it doubles its market capitalization north of $1 billion. The floor will be reduced to a market capitalization of $200 million, with 19 stock-traded companies cutting.
Three of the biggest stocks this year are twice as many as fubotv (fubo) 0.69%)), width (WRD) 27.14%))and Hims & Hers Health (HIMS) -2.27%)). Let's take a closer look at why these three companies will take off in 2025.
1. fubotv: 222% increase
Not only has it doubled in 2025, but it has actually tripled its stock. The live television streaming service was the hottest stock on the market in the first week of trading after landing a big cheese as an investor. Disney (dis -0.97%)) He signed a deal to become a 70% stakeholder on Fubo, and in the process he provided the business with a larger Hulu + Live TV platform.
At first it seemed like a shotgun wedding. Disney was working with two other Media Giants to launch Venu Sports, a streaming service that combines live sports programming from all three companies into a single subscription. Venu was hoping to roll out last year, but Fubo was able to use its own sports-centric platform to secure an injunction to block launches at least temporarily last summer. Ta.
Disney and Fubo banding along with live TV streaming services had a catch. Fubo filed a lawsuit against Venu, receiving a $220 million cash settlement in the process. It seemed like a rather clear case of rewarding the squeaky wheel, but the story then gave an even more interesting twist.
Image source: Getty Images.
Just a week after Disney and Fubo announced their new partnership, Venu Sports groped for the bundle. The three media giants behind the $43 streaming service have decided to go their separate ways. The fubo pairing with Disney continues.
Fubo meandered as a growing but profitable platform operator, but its operations were improved. I was hoping to make cash flow positive in 2025. It takes a long time to become a meaningful player with just 1.6 million premium accounts (less than 10% of the overall market) for a live television streaming service.
The new fubo will arrive at a total of 6.2 million homes, along with 4.6 million subscribers on Hulu + Live TV. There's scalability here, and Fubo has Disney audience reach and marketing muscles on its side.
2.
One day, and the number of notable investors almost doubled. Stocks of Chinese companies specializing in autonomous driving products and services spiked 81% on Friday nvidia (NVDA) 0.96%)) I became a minority investor. Weride had already beaten the market in 2025, but now it has more than doubled.
It's obviously a good thing to have a poster child for Artificial Intelligence (AI) – the second most valuable company in your corner by market capitalization. It was also a slightly vague and lightly traded company where Weride was just released in October for $15.50.
Two notes are guaranteed here. In particular, stocks will be launched that start this holiday subsidy week with openings even higher on Tuesday. Nvidia's disclosures were invested in the future last week in the fourth quarter, a very small position. That investment was worth just $25 million earlier this year. Weride's market capitalization jumped around $4 billion on Friday, following the news.
The second point is that Weride's revenue fell in 2023 throughout the first three quarters of 2024. This is a leader in the emerging industry, but investors are making big bets following Nvidia's small bets to prove a lot.
3. HIMS & HERS HEALTH: 150% increase
HIMS & HERS – Telehealth Specialist who offers a convenient and frequently discounted way to get everything from birth control to weight loss injections – surged 172% in 2024. At the end of last year, I didn't think it would happen within two months. Well, that happened.
The Telehealth platform was first launched as an online platform for men to carefully protect hair loss and erectile dysfunction medications. HIMS & HERS has been an impressive growth stock in the first few years of public trading, recording year-over-year growth of at least 45% for each quarter that is on the market.
HIMS & HERS accelerated from 46% to 52% in the first quarter last year, and later reports to 72%. Although they will not announce fourth quarter results until next week, analysts have seen a 90% rise in revenue this time.
The surge in popularity of weekly injectable GLP-1 treatments for weight loss has made things a step up. Novo Nordisk's (NVO) 4.92%)) Wegovy and Eli Lily's (lly 1.35%)) Zepbound has a patent to protect GLP-1 treatments specialized for weight loss, but the FDA loophole allows companies such as HIMS & HERS and other compounds to create copies of treatments processed during production shortages. can. Hims & Hers are taking off again this year as demand outweighs supply and the new administration is perceived as being kind to the compangers. And Hims & Hers, who advertise for the Super Bowl earlier this month, is fueling the momentum by calling for the greed of expensive, big drugs.
Rick Manalis has a job at Walt Disney. Motley Fools holds and recommends Nvidia, Walt Disney and Fubotv positions. Motley's Fool recommends Novo Nordisk. Motley Fools have a disclosure policy.
